Source: Annual Congress 2010 - Actual challenges in thoracic surgery
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
K. C. Ceylan, A. H. Arpat, D. Akpinar, S. O. Kaya (Izmir, Turkey). Clinicopathologic comparison of computed tomography and positron emission tomography scanning for mediastinal staging in NSCLC. Eur Respir J 2010; 36: Suppl. 54, 176

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 227s Year: 2001 Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration Source: Eur Respir J 2009; 33: 201-212 Year: 2009 Integrated positron emission tomography-computed tomography (PET-CT) in the staging of lung cancer Source: Annual Congress 2008 - New imaging modalities in the staging of lung cancer Year: 2008 Positron emission tomography (PET) and computed tomography (CT) in the assessment of the mediastinum for patients with presumed or established lung cancer Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs Year: 2008 Fluorodeoxyglucose positron emission tomography (FDG-PET) for detection and staging of bronchioloalveolar carcinoma Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 Imaging of malignant pleural mesothelioma with fluordeoxyglucose positron emission tomography (FDG-PET) Source: Eur Respir J 2001; 18: Suppl. 33, 396s Year: 2001 Imaging can replace mediastinoscopy: PRO Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005 Advances in chest imagery Source: Annual Congress 2006 - Clinical year in review Year: 2006 Single photon emission computed tomography (SPECT) in the non-invasive diagnosis cardiac sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 356s Year: 2006 Prognostic value of fluorine-18 fluorodeoxyglucose (18-FDG) positron emission tomography imaging in patients with non-small cell lung carcinoma Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Diagnostic imaging of lung cancer Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=120 Year: 2001 Imaging the inflammatory activity of sarcoidosis Source: Eur Respir J 2013; 41: 743-751 Year: 2013 Positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) for evaluation of indeterminate adrenal mass in patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002 Diagnostic imaging of lung cancer Source: Eur Respir J 2002; 19: 722-742 Year: 2002 Positron emission tomography in the diagnostic work-up of screening-detected lung nodules Source: Eur Respir J 2015; 45: 501-510 Year: 2015 Imaging in lung cancer: positron emission tomography scan Source: Eur Respir J 2002; 19: 49S-60S Year: 2002 Does prior mediastinal lymph node aspiration contribute to false-positive positron emission tomography–computed tomography? Source: ERJ Open Res, 6 (4) 00103-2020; 10.1183/23120541.00103-2020 Year: 2020 Radiology of lung cancer Source: Eur Respir Mon; 2009: 44: 106–135 Year: 2009 Imaging can replace mediastinoscopy: CON Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005 Silicoproteinosis – high-resolution computed tomography Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases Year: 2007